ASX - By Stock
|
IIQ |
Re:
Ann: INOVIQ Investor Update
|
|
Obelix999
|
14 |
4.8K |
9 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
14
|
4.8K
|
9
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: INOVIQ Investor Update
|
|
Obelix999
|
14 |
4.8K |
8 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
14
|
4.8K
|
8
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: INOVIQ Investor Update
|
|
Obelix999
|
14 |
4.8K |
9 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
14
|
4.8K
|
9
|
|
ASX - By Stock
|
DXB |
Re:
Dimerix (ASX: DXB) Discussion Thread
|
|
Obelix999
|
621 |
194K |
9 |
12/01/24 |
12/01/24 |
ASX - By Stock
|
621
|
194K
|
9
|
|
ASX - By Stock
|
MYS |
Re:
Ann: Q1 Trading Update
|
|
Obelix999
|
2 |
1.7K |
2 |
19/10/22 |
19/10/22 |
ASX - By Stock
|
2
|
1.7K
|
2
|
|
ASX - By Stock
|
ANZ |
Re:
Ann: ANZ completes Institutional Entitlement Offer
|
|
Obelix999
|
179 |
93K |
1 |
01/08/22 |
01/08/22 |
ASX - By Stock
|
179
|
93K
|
1
|
|
ASX - By Stock
|
PTX |
Re:
Information required?
|
|
Obelix999
|
21 |
7.8K |
5 |
26/11/21 |
26/11/21 |
ASX - By Stock
|
21
|
7.8K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
SNO 26th Annual Meeting
|
|
Obelix999
|
123 |
35K |
1 |
14/11/21 |
14/11/21 |
ASX - By Stock
|
123
|
35K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Obelix999
|
27 |
6.3K |
11 |
29/10/21 |
29/10/21 |
ASX - By Stock
|
27
|
6.3K
|
11
|
|
ASX - By Stock
|
IVX |
Re:
Ann: Complete Regression of TNBC Tumours and Protective Immunity
|
|
Obelix999
|
279 |
125K |
1 |
28/10/21 |
28/10/21 |
ASX - By Stock
|
279
|
125K
|
1
|
|
ASX - By Stock
|
VIP |
Re:
Ann: Investor corporate presentation
|
|
Obelix999
|
7 |
2.0K |
0 |
25/10/21 |
25/10/21 |
ASX - By Stock
|
7
|
2.0K
|
0
|
|
ASX - By Stock
|
SE1 |
Re:
Ann: Customer update (NanoDX)
|
|
Obelix999
|
145 |
41K |
3 |
08/10/21 |
08/10/21 |
ASX - By Stock
|
145
|
41K
|
3
|
|
ASX - By Stock
|
VIP |
Re:
Ann: Corporate Presentation to investors and shareholders
|
|
Obelix999
|
18 |
4.7K |
4 |
19/09/21 |
19/09/21 |
ASX - By Stock
|
18
|
4.7K
|
4
|
|
ASX - By Stock
|
SP3 |
Re:
Ann: Annual Report to shareholders and Appendix 4E
|
|
Obelix999
|
3 |
1.9K |
1 |
30/08/21 |
30/08/21 |
ASX - By Stock
|
3
|
1.9K
|
1
|
|
ASX - By Stock
|
VIP |
Re:
Ann: Preliminary Final Report
|
|
Obelix999
|
30 |
8.9K |
7 |
30/08/21 |
30/08/21 |
ASX - By Stock
|
30
|
8.9K
|
7
|
|
ASX - By Stock
|
BP8 |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Obelix999
|
203 |
32K |
2 |
02/08/21 |
02/08/21 |
ASX - By Stock
|
203
|
32K
|
2
|
|
ASX - By Stock
|
K2F |
Re:
Ann: K2F Appendix 4C - Quarterly Cash Flow Report
|
|
Obelix999
|
40 |
10K |
0 |
29/07/21 |
29/07/21 |
ASX - By Stock
|
40
|
10K
|
0
|
|
ASX - By Stock
|
SP3 |
Re:
Ann: Addendum - Quarterly Activities Report - June 2021
|
|
Obelix999
|
44 |
12K |
2 |
20/07/21 |
20/07/21 |
ASX - By Stock
|
44
|
12K
|
2
|
|
ASX - By Stock
|
SE1 |
Re:
USD $10 million + of COVID detection sensor orders..
|
|
Obelix999
|
278 |
80K |
1 |
15/07/21 |
15/07/21 |
ASX - By Stock
|
278
|
80K
|
1
|
|
ASX - By Stock
|
SE1 |
Re:
USD $10 million + of COVID detection sensor orders..
|
|
Obelix999
|
278 |
80K |
2 |
15/07/21 |
15/07/21 |
ASX - By Stock
|
278
|
80K
|
2
|
|
ASX - By Stock
|
VIP |
Re:
Ann: Appointment of group Managing Director
|
|
Obelix999
|
9 |
3.1K |
4 |
26/05/21 |
26/05/21 |
ASX - By Stock
|
9
|
3.1K
|
4
|
|
ASX - By Stock
|
VIP |
Re:
Ann: VIP Operations Update
|
|
Obelix999
|
108 |
27K |
1 |
11/05/21 |
11/05/21 |
ASX - By Stock
|
108
|
27K
|
1
|
|
ASX - By Stock
|
VIP |
Re:
Ann: VIP Operations Update
|
|
Obelix999
|
108 |
27K |
0 |
06/05/21 |
06/05/21 |
ASX - By Stock
|
108
|
27K
|
0
|
|
ASX - By Stock
|
VIP |
Re:
Ann: VIP Operations Update
|
|
Obelix999
|
108 |
27K |
3 |
06/05/21 |
06/05/21 |
ASX - By Stock
|
108
|
27K
|
3
|
|
ASX - By Stock
|
VIP |
Re:
Ann: VIP Operations Update
|
|
Obelix999
|
108 |
27K |
3 |
05/05/21 |
05/05/21 |
ASX - By Stock
|
108
|
27K
|
3
|
|
ASX - By Stock
|
NSB |
Re:
Potential 100 bagger Biotech missed by the market
|
|
Obelix999
|
1.5K |
456K |
3 |
05/05/21 |
05/05/21 |
ASX - By Stock
|
1.5K
|
456K
|
3
|
|
ASX - By Stock
|
VIP |
Re:
Ann: VIP Operations Update
|
|
Obelix999
|
108 |
27K |
7 |
05/05/21 |
05/05/21 |
ASX - By Stock
|
108
|
27K
|
7
|
|
ASX - By Stock
|
VIP |
Re:
Ann: VIP Operations Update
|
|
Obelix999
|
108 |
27K |
1 |
04/05/21 |
04/05/21 |
ASX - By Stock
|
108
|
27K
|
1
|
|
ASX - By Stock
|
SE1 |
Re:
Ann: Quarterly Update and Appendix 4C
|
|
Obelix999
|
97 |
24K |
2 |
30/04/21 |
30/04/21 |
ASX - By Stock
|
97
|
24K
|
2
|
|
ASX - By Stock
|
IIQ Biotech |
Re:
Pending testing results
|
|
Obelix999
|
306 |
143K |
2 |
30/04/21 |
30/04/21 |
ASX - By Stock
|
306
|
143K
|
2
|
|
ASX - By Stock
|
IIQ Biotech |
Re:
Pending testing results
|
|
Obelix999
|
306 |
143K |
1 |
30/04/21 |
30/04/21 |
ASX - By Stock
|
306
|
143K
|
1
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Positive Results from the BARD1 Autoantibody Assay
|
|
Obelix999
|
69 |
18K |
4 |
29/04/21 |
29/04/21 |
ASX - By Stock
|
69
|
18K
|
4
|
|
ASX - By Stock
|
IIQ Biotech |
Re:
Griffith university CEO phone call
|
|
Obelix999
|
34 |
13K |
4 |
22/04/21 |
22/04/21 |
ASX - By Stock
|
34
|
13K
|
4
|
|
ASX - By Stock
|
BP8 |
Re:
Ann: Half Yearly Report and Accounts
|
|
Obelix999
|
24 |
6.1K |
2 |
09/04/21 |
09/04/21 |
ASX - By Stock
|
24
|
6.1K
|
2
|
|
ASX - By Stock
|
SE1 |
Re:
Time for some good news
|
|
Obelix999
|
417 |
116K |
8 |
08/04/21 |
08/04/21 |
ASX - By Stock
|
417
|
116K
|
8
|
|
ASX - By Stock
|
SE1 |
Re:
Time for some good news
|
|
Obelix999
|
417 |
116K |
7 |
07/04/21 |
07/04/21 |
ASX - By Stock
|
417
|
116K
|
7
|
|
ASX - By Stock
|
ANR |
Re:
Ann: Market Update
|
|
Obelix999
|
4 |
1.7K |
3 |
07/04/21 |
07/04/21 |
ASX - By Stock
|
4
|
1.7K
|
3
|
|
ASX - By Stock
|
SE1 |
Re:
US $3m+ of COVID Detection Sensor Orders
|
|
Obelix999
|
153 |
41K |
6 |
20/03/21 |
20/03/21 |
ASX - By Stock
|
153
|
41K
|
6
|
|
ASX - By Stock
|
SE1 |
Re:
US $3m+ of COVID Detection Sensor Orders
|
|
Obelix999
|
153 |
41K |
4 |
20/03/21 |
20/03/21 |
ASX - By Stock
|
153
|
41K
|
4
|
|
ASX - By Stock
|
SE1 |
Re:
US $3m+ of COVID Detection Sensor Orders
|
|
Obelix999
|
153 |
41K |
6 |
18/03/21 |
18/03/21 |
ASX - By Stock
|
153
|
41K
|
6
|
|
ASX - By Stock
|
SE1 |
Re:
US $3m+ of COVID Detection Sensor Orders
|
|
Obelix999
|
153 |
41K |
5 |
12/03/21 |
12/03/21 |
ASX - By Stock
|
153
|
41K
|
5
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Ceasing to be a substantial holder
|
|
Obelix999
|
52 |
12K |
5 |
13/12/20 |
13/12/20 |
ASX - By Stock
|
52
|
12K
|
5
|
|
ASX - By Stock
|
IBX |
Re:
IBXO
|
|
Obelix999
|
12 |
4.5K |
17 |
13/12/20 |
13/12/20 |
ASX - By Stock
|
12
|
4.5K
|
17
|
|
ASX - By Stock
|
MYS |
Re:
Ann: Chairman's Address to Shareholders
|
|
Obelix999
|
13 |
3.3K |
0 |
20/11/20 |
20/11/20 |
ASX - By Stock
|
13
|
3.3K
|
0
|
|
ASX - By Stock
|
VML |
Re:
Ann: Quarterly Activities and Cashflow Report
|
|
Obelix999
|
39 |
11K |
5 |
30/10/20 |
30/10/20 |
ASX - By Stock
|
39
|
11K
|
5
|
|
ASX - Short Term Trading
|
|
Re:
Short Term Trading Week Starting: 26 Oct
|
|
Obelix999
|
93 |
18K |
6 |
29/10/20 |
29/10/20 |
ASX - Short Term Trading
|
93
|
18K
|
6
|
|
ASX - By Stock
|
MYS |
Re:
Ann: Chairman's Address to Shareholders
|
|
Obelix999
|
13 |
3.3K |
0 |
21/10/20 |
21/10/20 |
ASX - By Stock
|
13
|
3.3K
|
0
|
|
ASX - By Stock
|
MYS |
Re:
Ann: Chairman's Address to Shareholders
|
|
Obelix999
|
13 |
3.3K |
3 |
21/10/20 |
21/10/20 |
ASX - By Stock
|
13
|
3.3K
|
3
|
|
ASX - By Stock
|
DXB |
Re:
Recce Pharmaceuticals (ASX:RCE) gains ethics approval to start burns study
|
|
Obelix999
|
12 |
4.6K |
4 |
19/10/20 |
19/10/20 |
ASX - By Stock
|
12
|
4.6K
|
4
|
|
ASX - By Stock
|
DXB |
Re:
sub analysis overdue
|
|
Obelix999
|
193 |
58K |
2 |
15/10/20 |
15/10/20 |
ASX - By Stock
|
193
|
58K
|
2
|
|